Inotiv Inc (NOTV) Growth Rates Comparisons to Medical Laboratories Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Inotiv Inc   (NASDAQ: NOTV)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Inotiv Inc Growth Comparisons

Select each growth Category to receive further Information





NOTV Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -5.37 % 9.3 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -2.67 % -4.17 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 5.61 % 9.49 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) -1.3 % 2.32 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 53.36 % 13.12 % 8.65 % 10.59 %


NOTV's Growth Comparisons in II. Quarter 2026




Although the Medical Laboratories industry saw advancing Revenue by 9.3%, Inotiv Inc announced -5.37% year on year sales decline in the second quarter 2026, to $ 118 millions, and underperformed the 8.91% Revenue growth in the Healthcare sector. Weak second quarter sales, in Medical Laboratories industry and within the Healthcare sector, were reflected in Inotiv Inc results which underperformed overall market.

Top-line fell by -2.67% from the first quarter. Average annual sales growth for Inotiv Inc is 53.36%, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the second quarter 2026 financial results.

NOTV Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
InterEliminations
-
-
Service
4.13 %
-2.13 %
Product
-13.18 %
-3.19 %
Discovery and Safety Assessment Segment
3.86 %
-1.82 %
Discovery and Safety Assessment Service
3.43 %
-1.77 %
Discovery and Safety Assessment Product
19.34 %
-3.28 %
Research Models And Services Segment
-10.66 %
-3.23 %
Research Models And Services Service
6.71 %
-3.4 %
Research Models And Services Product
-13.78 %
-3.19 %
United States
-7.55 %
-0.03 %
Netherlands
38.34 %
-35.92 %
Other
0.46 %
5.14 %
Total
-5.37 %
-2.67 %


Growth Rates of NOTV's Income in the second quarter 2026


NOTV Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 51.98 % 4.62 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) - 0.29 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 91.48 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) - 10.42 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 6.34 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - 29.87 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - 7.6 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 3.68 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - 14.82 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 5.07 % 0.17 % -28.52 %

NOTV Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - 10.96 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) - 6.76 % -0.77 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - 186.84 % 15.51 % 57.33 %
Sequential Net Income Change (Q1 TTM) - 13.58 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth - 5.34 % 9.21 % 22.96 %

NOTV's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - 21.52 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - 1.6 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -8.23 % 0.17 % -28.52 %



NOTV EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - 3.82 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q1 MRQ) - 0.81 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - - 4.93 %
EPS Net 5 Year Avg. Change - 5.34 % 9.21 % 22.96 %



Inotiv Inc reported bottom-line of $ -0.94 in the second quarter, compare to $ -0.44 in the same quarter a year ago. Medical Laboratories industry grew by 3.82%, while Healthcare sector decreased by -26.26%, and overall market improved by 90.69%.

the bottom-line fell by -2.67% from the first quarter. Average annual income per share growth for Inotiv Inc is 53.36%, while S & P 500's average yearly income per share increase is 22.96%, including only Businesses with the second quarter 2026 earnings.

NOTV Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -2.81 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - -74.49 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) - 28.27 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) - 0.68 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 10.39 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - 16.28 % - 152.64 %
Net Cash Flow 5 Year Avg. Change -17.33 % -9.51 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -61.58 % 46.14 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) -59.4 % -1.79 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) -28.92 % 23.91 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) -19.44 % 11.21 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change 21.79 % 8.61 % 9.12 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.